Investment
Features
FeesSafety
Academy
More
Pluang+

Thunder Gold reports strong gold drill results at Tower Mountain, expanding resource potential.

Market News
19 Oct 2026
Newsfile Corp
View Source
Bullish
Thunder Gold reports strong gold drill results at Tower Mountain, expanding resource potential.

Thunder Gold Corp. announced promising exploration results from its Tower Mountain property in Ontario, with drill holes intersecting significant gold mineralization, including 1.178 g/t Au over 102 meters. These results confirm and exceed the 2026 Mineral Resource Estimate, showing continuous gold presence and potential for expansion at depth. The company is increasing drilling efforts and has completed a MagnetoTellurics airborne survey to further explore mineralization to depths of up to 2 kilometers. This progress supports the potential for a large, scalable gold resource at Tower Mountain.

Thunder Gold's exploration update at Tower Mountain provides context for readers following Basic Materials. As of Oct 19, 2026 18:11 WIB, among 83 priced Basic Materials-sector US stocks tradable on Pluang, 44 rose and 29 fell. Notable movers include STLD at USD 243.96 with a 1-day change of +1.42%, JCI at USD 147.46 with +1.37%, and ESI at USD 35.52 with +1.34%.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
46 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
46 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
46 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
46 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
46 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App